Chris Krawtschuk
Chief Financial Officer @ bluebird bio
About Chris Krawtschuk
Chris Krawtschuk is the Chief Financial Officer with a background in finance at notable companies and a personal commitment to community involvement through managing his sons' baseball teams.
Known information
Chris Krawtschuk serves as the Chief Financial Officer, bringing extensive experience from his previous roles in the financial sector. He began his career at PwC, where he was a Managing Director in the Capital Markets and Accounting Advisory Practice. Chris has also held the position of CFO at Jubilant Pharma and MorphoSys US, demonstrating a robust track record in financial management within the pharmaceutical industry. He holds a BS in Accounting from William Paterson University and is a licensed CPA. Beyond his professional endeavors, Chris dedicates time to his community by managing baseball teams for both of his sons on weekends.
About bluebird bio
Bluebird bio develops gene therapies for severe genetic disorders, utilizing a proprietary lentiviral vector platform, and has an FDA-approved treatment for sickle cell disease.